Man Chun John Ma

7PUBLICATIONS
67CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 11, 2022
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma.

Jason Westin, R Eric Davis, Lei Feng

|Jun 10, 2022
Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression.

Guangchun Han, Qing Deng, Mario L Marques-Piubelli

|Jan 11, 2022
Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma.

Loretta J Nastoupil, Collin K Chin, Jason R Westin

|Jan 10, 2020
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma.

Patrizia Mondello, Saber Tadros, Matt Teater

|Jun 21, 2019
Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma.

Neeraj Jain, Keenan Hartert, Saber Tadros

Pageof 2